Financhill
Back

Alnylam Pharmaceuticals Vs. Biomarin Pharmaceutical Industry Stock Comparison

Sell
35

ALNY
Alnylam Pharmaceuticals

Last Price:
277.35
Seasonality Move:
10.72%
Buy
61

BMRN
Biomarin Pharmaceutical

Last Price:
67.07
Seasonality Move:
13.3%
Sell
35
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $277.43. The Score for ALNY is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $67.07. The Score for BMRN is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $277.43
    The current trend is relatively stagnant and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $67.07
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.2 Sell
Relative Strength Index (14 RSI): 49.43 Sell
Chaikin Money Flow: 435362 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (270.23 - 291.39) Sell
Bollinger Bands (100): (237.21 - 286.27) Buy

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.77 Sell
Relative Strength Index (14 RSI): 36.99 Sell
Chaikin Money Flow: 38184 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (67.11 - 70.53) Sell
Bollinger Bands (100): (70.87 - 88.17) Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 272.5 Buy
20-day SMA: 283.25 Sell
50-day SMA: 273.97 Buy
200-day SMA: 207.84 Buy
8-day EMA: 274.92 Buy
20-day EMA: 277.83 Sell
50-day EMA: 272.73 Buy
200-day EMA: 228.92 Buy

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 66.42 Buy
20-day SMA: 68.68 Sell
50-day SMA: 73.15 Sell
200-day SMA: 82.32 Sell
8-day EMA: 67.03 Buy
20-day EMA: 68.41 Sell
50-day EMA: 72.52 Sell
200-day EMA: 80.98 Sell

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.48 per share, and an increase next year of $0.66 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.25 per share, and an increase next year of $0.80 per share.

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):